Theriva Biologics TOVX
NYSE TOVX
$0.23 +0.01 (+2.40%)
As of: Oct 1, 2026 · 3:56 PM EDT

Theriva Biologics (TOVX) Non Operating Income (2010 - 2026)

Updated

Theriva Biologics (TOVX) posted Non Operating Income of $78,000 for Q2 2026, up 5.4% from $74,000 a year earlier but down 6.0% from the prior quarter.

Analysis

Theriva Biologics (TOVX) Non Operating Income (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Non Operating Income at Theriva Biologics was $307,000, down 33.4% year-over-year; for FY2025, it came in at $312,000, down 55.0% from FY2024.

  • Annual Non Operating Income shows a five-year compound annual growth rate of 48.0% (FY2020 to FY2025).
  • In prior years, Theriva Biologics' Non Operating Income was $693,000 in FY2024 (-51.9%), $1.44 million in FY2023 (+206.2%), $471,000 in FY2022 and $6,000 in FY2021 (-86.4%).
  • Quarterly Non Operating Income has run from a low of -$21,000 in Q1 2022 to a high of $388,000 in Q3 2023 over five years.
  • On a year-over-year basis, Non Operating Income increased in 1 of the last eight quarters, with an average decline of 42.2%.
  • The strongest year-over-year quarter for Non Operating Income in the past five years was Q2 2022, with growth of 750.0%; the weakest was Q1 2025, with a decline of 59.0%.
  • According to Business Quant data, Non Operating Income for the three prior quarters was $83,000 (Q1 2026), $67,000 (Q4 2025) and $79,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Theriva Biologics 10.56 Mn 10.56 Mn - 78,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 78,000.00
Mar 31, 2026 83,000.00
Dec 31, 2025 67,000.00
Sep 30, 2025 79,000.00
Jun 30, 2025 74,000.00
Mar 31, 2025 93,000.00
Dec 31, 2024 133,000.00
Sep 30, 2024 161,000.00
Jun 30, 2024 172,000.00
Mar 31, 2024 227,000.00
Dec 31, 2023 308,000.00
Sep 30, 2023 388,000.00
Jun 30, 2023 377,000.00
Mar 31, 2023 370,000.00
Dec 31, 2022 314,000.00
Sep 30, 2022 161,000.00
Jun 30, 2022 17,000.00
Mar 31, 2022 -21,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 2,000.00
API Access

Theriva Biologics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=TOVX&period=max&api_key=YOUR_API_KEY